MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Lung Cancer

The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.

Journal of Cancer Research and Clinical Oncology 2018 August 3 [Link] Liu XL, Zuo R, Ou WB Abstract PURPOSE: Lung cancer and mesothelioma are two types of respiratory disease that have fatal courses and poor prognoses. Although a substantial number of targeted small molecules and antibody drugs have been developed, the 5-year survival rates of […]

Comments Off on The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.

The characteristics of asbestos-related disease claims made to the Korea Workers’ Compensation and Welfare Service (KCOMWEL) from 2011 to 2015.

Annals of Occupational and Environmental Medicine 2018 July 11 [Link] An YS, Kim HD, Kim HC, Jeong KS, Ahn YS Abstract BACKGROUND: This study aimed to enhance understanding of the epidemiologic characteristics of asbestos-related diseases, and to provide information that could inform policy-making aimed at prevention and compensation for occupational asbestos exposure, through analyzing asbestos-related […]

Comments Off on The characteristics of asbestos-related disease claims made to the Korea Workers’ Compensation and Welfare Service (KCOMWEL) from 2011 to 2015.

Measuring EMPs in the lung what can be measured in the lung: Asbestiform minerals and cleavage fragments.

Toxicology and Applied Pharmacology 2018 June 27 [Link] Roggli VL Abstract Asbestos mineral fibers have been associated with the development of a variety of diseases in humans and experimental animals, including asbestosis, lung cancer, and mesothelioma. Asbestos includes several mineral types divided into two mineral groups, serpentine and amphibole forms. Chrysotile is the serpentine mineral […]

Comments Off on Measuring EMPs in the lung what can be measured in the lung: Asbestiform minerals and cleavage fragments.

Cancer incidence in a cohort of asbestos-exposed workers undergoing health surveillance.

International Archives of Occupational and Environmental Health 2018 June 5 [Link] Barbiero F, Zanin T, Pisa FE, Casetta A, Rosolen V, Giangreco M, Negro C, Bovenzi M, Barbone F Abstract OBJECTIVES: To compare a local cohort of 2488 men occupationally exposed to asbestos and enrolled in a public health surveillance program with the 1995-2009 cancer […]

Comments Off on Cancer incidence in a cohort of asbestos-exposed workers undergoing health surveillance.

The current aetiology of malignant pleural effusion in the Western Cape Province, South Africa

South African Medical Journal 2018 March 28 [Link] Koegelenberg CFN1, Bennji SM, Boer E, Schubert PT, Shaw JA, Allwood BW, Irusen EM Abstract BACKGROUND: Malignant pleural effusion (MPE) represents a very common cause of pleural exudates, and is one of the most challenging pleural disorders to manage. This could be attributed to the paucity of […]

Comments Off on The current aetiology of malignant pleural effusion in the Western Cape Province, South Africa

Survivin is a negative prognostic factor in malignant pleural effusion

European Journal of Clinical Investigation 2018 January 23 [Epub ahead of print] [Link] Arellano-Orden E et. al. Abstract SURVIVIN: is a well-known member of the inhibitor of apoptosis family, and has been related with increased tumour aggressivity, both in tissue and in pleural fluid. OBJECTIVES: In patients with malignant pleural effusion, we sought to investigate […]

Comments Off on Survivin is a negative prognostic factor in malignant pleural effusion

Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients

Supportive Care In Cancer 2018 February [Epub ahead of print] [Link] Gelhorn H et. al. Abstract PURPOSE: Obtaining qualitative data directly from the patient perspective enhances the content validity of patient-reported outcome (PRO) instruments. The objective of this qualitative study was to evaluate the content validity of the Lung Cancer Symptom Scale for Mesothelioma (LCSS-Meso) […]

Comments Off on Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients

Progress in the Management of Advanced Thoracic Malignancies in 2017

Journal of Thoracic Oncology 2018 January 10 [Epub ahead of print] [Link] Ferrara R, Mezquita L, Besse B Abstract The treatment paradigm of non-small cell lung cancer (NSCLC) underwent a major revolution during the course of 2017. Immune checkpoint inhibitors (ICIs) brought remarkable improvements in response and overall survival (OS) both in unselected pretreated patients […]

Comments Off on Progress in the Management of Advanced Thoracic Malignancies in 2017

Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies

Journal of Thoracic Oncology 2017 October [Epub ahead of print] [Link] Kiesgen S, Chicaybam L, Chintala NK, Adusumilli PS Abstract Chimeric antigen receptor (CAR) T cells are patient T cells that are transduced with genetically engineered synthetic receptors to target a cancer cell surface antigen. The remarkable clinical response rates achieved by adoptive transfer of […]

Comments Off on Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies

Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis

European Journal of Surgical Oncology 2017 September [Epub ahead of print] [Link] Alyami M, Gagniere J, Sgarbura O, Cabelguenne D, Villeneuve L, Pezet D, Quenet F, Glehen O, Bakrin N, Passot G Abstract BACKGROUND: PIPAC is a recent approach for intraperitoneal chemotherapy with promising results for patients with peritoneal carcinomatosis (PC). We aimed to evaluate […]

Comments Off on Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis